DNA识别受体PYHIN家族及相关病毒免疫逃逸机制的研究

宿主细胞内的DNA识别受体可识别病毒核酸分子并激活细胞天然免疫反应,从而产生抗病毒效应;同时,病毒也进化出相应机制来逃避或抑制这种免疫反应。本文总结了宿主细胞内DNA识别受体PYHIN家族识别病毒核酸并激活细胞天然免疫反应的特点和分子机制,并讨论了病毒逃避宿主天然免疫应答的方式。     

泛素化调控抗病毒天然免疫的研究进展

天然免疫是宿主防御病原微生物入侵的第一道防线,其活化主要通过天然免疫细胞上的模式识别受体(pattern recognition receptors, PRRs)识别病原微生物上相对保守的相关分子模式(pathogen-associated molecular patterns, PAMPs).病毒相关的核酸成分可以被机体Toll样受体(Toll-like receptors, TLRs)、维甲酸诱导基因Ⅰ受体(RIG-I-like receptors, RLRs)以及胞浆DNA受体(cytoplasmic DNA sensors)等识别,通过一系列复杂的细胞信号通路诱导Ⅰ型干扰素(typeⅠinterferon)及炎症因子的表达,从而激发机体抗病毒反应.泛素化修饰是细胞内广泛存在的蛋白质翻译后修饰方式,在宿主防御病原微生物感染的动态调控过程中发挥着重要的作用.已有大量文献报道,天然免疫抗病毒信号通路中的多个关键接头分子可发生泛素化修饰,进而调控机体抗病毒免疫应答反应.本文综述了泛素化修饰在抗病毒天然免疫中的作用及其调控机制.     

cGAS-STING信号通路：免疫监视的重要机制

免疫系统识别病原微生物的主要机制之一是识别其核酸。环磷酸鸟苷-腺苷合成酶(cGAS)是一种胞质DNA感受器,感知病原DNA后激活cGAS-STING通路。该通路不仅介导天然免疫应答以抵抗多种含DNA的病原微生物感染,还能感知肿瘤来源的DNA而产生抗肿瘤免疫应答。然而,自体DNA对cGAS-STING通路的异常激活也会导致自身免疫性和炎症性疾病。本文综述了cGAS-STING信号通路及其在抗病毒天然免疫中的调控作用与功能,阐述了cGAS-STING通路在抗病毒感染和疾病中发挥的作用。     

CpG DNA特异性识别的关键蛋白Toll样受体-9

Toll样受体在对抗外来病原微生物的天然免疫应答中发挥中心作用。新发现的一种分子识别模型受体Toll样受体-9（TLR9）,能特异性识别CpG DNA并起动信号转导级联反应,在不同种类中的TLR9具有对序列识别的特异性。本文概述国外在TLR9识别作用机制和生物学活性研究中已取得的进展,并提出了今后研究的发展方向。     

TLR9介导DNA病毒的免疫识别

Toll样受体(toll-like receptor,TLR)是免疫细胞表面的模式识别受体(patttern recognition receptoi,PRR),参与微生物病原体相关分子模式(pathogen associated molecular patterns,PAMPs)的识别,从而诱导天然免疫应答。迄今在人类已经确定了10个TLRs家族成员。不同的TLRs识别不同的PAMPs,如TLR9是免疫细胞识别病毒和细菌中非甲基化DNA的必需成分;     

水中病原微生物分子检测技术研究进展

基于PCR方法的多种分子检测技术已广泛的应用于水体病原微生物的检测中。而以DNA芯片为代表的微型化、快速化手段将是未来检测技术的发展方向,可实现对病原微生物实时和快速的检测。新检测技术的发展有利于建立水体污染早期预警机制,同时,可靠的病原微生物检测方法可降低有害微生物对人类健康的影响。对水体病原微生物分子检测方法及其在水污染相关疾病风险控制中所扮演的重要角色进行阐述。     

我国科学家揭示抗病毒天然免疫新机制

正中科院动物所孙钦秒团队在抗病毒天然免疫新机制研究方面取得进展。相关成果日前发表于《自然-通讯》杂志。据了解,天然免疫系统是机体抵抗病原微生物入侵的第一道防线。它首先通过模式识别受体与病原体相关分子模式相互识别,进一步激活一系列免疫反应。与此同     

细菌病原体突破天然免疫系统的策略

近10年来,天然免疫和病原微生物两个相关领域研究取得了巨大进展。面对功能完备的天然免疫系统,一些病原微生物感染宿主的机制逐步进化了,并且病原体通过此进化避免被识别,促进或避免炎症的产生。事实证明,病原体不仅能在天然免疫反应中幸存,而且还能利用天然免疫反应来提高它的致病性。     

模式识别受体介导的病原免疫逃逸

天然免疫通过细胞模式识别受体识别病原相关分子模式来清除感染。但是,在长期的进化过程中,许多病原体已经形成了自身的保护机制,从而逃逸天然免疫的杀伤。综述了模式识别受体介导的病原体的主要逃逸机制,以期为疾病的控制和预防提供新认识。     

宿主识别与应答胞质内DNA入侵的信号转导机制

固有免疫是宿主防御病原微生物入侵的第一道防线。宿主通过胚系基因编码的模式识别受体(pathogen recognition receptor,PRR)监测微生物的病原相关分子模式(病毒核酸等),迅速启动免疫应答反应。宿主自身的核酸如果错误地出现在细胞质中,也会被模式识别受体识别,引发自身免疫疾病。STING(stimulator of interferon genes)是最近鉴定出的内质网接头蛋白,可以动态监控细胞内DNA以及环二核苷酸(cyclic dinucleotides,CDNs)的异常存在,发挥承上启下的抗微生物感染的枢纽功能。该文概述STING介导的细胞信号通路前沿进展,并对有待突破的科学问题作出展望。     

Mitochondrial DNA in the regulation of innate immune responses

Mitochondrion is known as the energy factory of the cell, which is also a unique mammalian organelle and considered to be evolved from aerobic prokaryotes more than a billion years ago. Mitochondrial DNA, similar to that of its bacterial ancestor’s, consists of a circular loop and contains significant number of unmethylated DNA as CpG islands. The innate immune system plays an important role in the mammalian immune response. Recent research has demonstrated that mitochondrial DNA (mtDNA) activates several innate immune pathways involving TLR9, NLRP3 and STING signaling, which contributes to the signaling platforms and results in effector responses. In addition to facilitating antibacterial immunity and regulating antiviral signaling, mounting evidence suggests that mtDNA contributes to inflammatory diseases following cellular damage and stress. Therefore, in addition to its well-appreciated roles in cellular metabolism and energy production, mtDNA appears to function as a key member in the innate immune system. Here, we highlight the emerging roles of mtDNA in innate immunity.     

Herpes simplex viruses and induction of interferon responses

Herpes simplex viruses (HSV) are human pathogens responsible for a variety of diseases,including localized mucocutaneous lesions,encephalitis,and disseminated diseases.HSV infection leads to rapid induction of innate immune responses.A critical part of this host response is the type I IFN system including the induction of type I IFNs,IFN-mediated signaling and amplification of IFN response.This provides the host with immediate countermeasure during acute infection to limit initial viral replication and to facilitate an appropriate adaptive immune response.However,HSV has devised multiple strategies to evade and interfere with innate immunity.This review will focus on the induction of type I IFN response by HSV during acute infection and current knowledge of mechanisms by which HSV interferes with this induction process.     

Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems

Recognition of viruses by germ line-encoded pattern recognition receptors of the innate immune system is essential for rapid production of type I interferon (IFN) and early antiviral defense. We investigated the mechanisms of viral recognition governing production of type I IFN during herpes simplex virus (HSV) infection. We show that early production of IFN in vivo is mediated through Toll-like receptor 9 (TLR9) and plasmacytoid dendritic cells, whereas the subsequent alpha/beta IFN (IFN-α/β) response is derived from several cell types and induced independently of TLR9. In conventional DCs, the IFN response occurred independently of viral replication but was dependent on viral entry. Moreover, using a HSV-1 UL15 mutant, which fails to package viral DNA into the virion, we found that entry-dependent IFN induction also required the presence of viral genomic DNA. In macrophages and fibroblasts, where the virus was able to replicate, HSV-induced IFN-α/β production was dependent on both viral entry and replication, and ablated in cells unable to signal through the mitochondrial antiviral signaling protein pathway. Thus, during an HSV infection in vivo, multiple mechanisms of pathogen recognition are active, which operate in cell-type- and time-dependent manners to trigger expression of type I IFN and coordinate the antiviral response.     

Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways

Recombinant adenoviral vectors have been widely used for gene therapy applications and as vaccine vehicles for treating infectious diseases such as human immunodeficiency virus disease. The innate immune response to adenoviruses represents the most significant hurdle in clinical application of adenoviral vectors for gene therapy, but it is an attractive feature for vaccine development. How adenovirus activates innate immunity remains largely unknown. Here we showed that adenovirus elicited innate immune response through the induction of high levels of type I interferons (IFNs) by both plasmacytoid dendritic cells (pDCs) and non-pDCs such as conventional DCs and macrophages. The innate immune recognition of adenovirus by pDCs was mediated by Toll-like receptor 9 (TLR9) and was dependent on MyD88, whereas that by non-pDCs was TLR independent through cytosolic sensing of adenoviral DNA. Furthermore, type I IFNs were pivotal in innate and adaptive immune responses to adenovirus in vivo, and type I IFN blockade diminished immune responses, resulting in more stable transgene expression and reduction of inflammation. These findings indicate that adenovirus activates innate immunity by its DNA through TLR-dependent and -independent pathways in a cell type-specific fashion, and they highlight a critical role for type I IFNs in innate and adaptive immune responses to adenoviral vectors. Our results that suggest strategies to interfere with type I IFN pathway may improve the outcome of adenovirus-mediated gene therapy, whereas approaches to activate the type I IFN pathway may enhance vaccine potency.     

DNA模式识别受体研究进展

固有免疫系统利用模式识别受体识别病原相关分子模式。近期研究发现,外源DNA能够被宿主细胞中多种DNA受体识别,激活多种信号通路,上调Ⅰ型干扰素和促炎性细胞因子的表达。基于DNA的免疫识别在激活宿主抗感染免疫过程中起重要作用,因此仅对现已报道的DNA受体进行概述,同时对DNA的免疫识别与自身免疫病之间的关系进行探讨。     

H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection

Persistent infection with the gastric bacterial pathogen Helicobacter pylori causes gastritis and predisposes carriers to a high gastric cancer risk, but has also been linked to protection from allergic, chronic inflammatory and autoimmune diseases. In the course of tens of thousands of years of co-existence with its human host, H. pylori has evolved elaborate adaptations that allow it to persist in the hostile environment of the stomach in the face of a vigorous innate and adaptive immune response. For this review, we have identified several key immune cell types and signaling pathways that appear to be preferentially targeted by the bacteria to establish and maintain persistent infection. We explore the mechanisms that allow the bacteria to avoid detection by innate immune cells via their pattern recognition receptors, to escape T-cell mediated adaptive immunity, and to reprogram the immune system towards tolerance rather than immunity. The implications of the immunomodulatory properties of the bacteria for the prevention of allergic and auto-immune diseases in chronically infected individuals are also discussed.     

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus

Background

Cancer stem cells/initiating cells (CSC/CIC), are thought to exist as a small population in malignant tissues. They are resistant to conventional cancer treatments and possibly underlie post-treatment relapse. The CIC population can be targeted with capsid modified oncolytic adenoviruses.

Methodology/Principal Findings

We studied the mechanisms of innate immunity to oncolytic adenovirus Ad5/3-Delta24 in conventional treatment resistant non-CIC breast cancer cells, breast cancer CD44⁺/CD24^−/low CIC population and normal breast tissue CD44⁺/CD24^−/low stem cells. We compared virus recognition by pattern recognition receptors for adenovirus, Toll-like receptors (TLR) 2 and 9 and virus induced type I interferon (IFN) response regulation in these cell types. We show TLR mediated virus recognition in these non-immune cell types. Normal tissue stem cells have intact type I IFN signaling. Furthermore, TLR9 and TLR2 reside constantly in recognition sites, implying constant activation. In contrast, breast cancer CD44⁺/CD24^−/low CIC have dysregulated innate immune responses featuring dysfunctional virus recognition caused by impaired trafficking of TLR9 and cofactor MyD88 and the absence of TLR2, having a deleterious impact on TLR pattern recognition receptor signaling. Furthermore, the CIC have increased inhibitory signaling via the suppressor of cytokine signaling/Tyro3/Axl/Mer receptor tyrosine kinase (SOCS/TAM) pathway. These defects in contribute to dysfunctional induction of type I IFN response in CIC and therefore permissivity to oncolytic adenovirus.

Conclusions/Significance

CICs may underlie the incurable nature of relapsed or metastatic cancers and are therefore an important target regarding diagnostic and prognostic aspects as well as treatment of the disease. This study addresses the mechanisms of innate infection immunity in stem cells deepening the understanding of stem cell biology and may benefit not only virotherapy but also immunotherapy in general.